Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40009649
Localisation
India
Asia
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
17/04/2025
Statut
Classification
1.5°C
Année cible
FY2029
Statut
Targets set
Classification
1.5°C
Année cible
FY2049
Overall Net-Zero Target: Aarti Pharmalabs Limited commits to reach net-zero greenhouse gas emissions across the value chain by FY2050. Near-Term Targets: Aarti PharmaLabs Limited commits to reduce absolute scope 1 and 2 GHG emissions 37.8% by FY2030 from a FY2024 base year.* Aarti PharmaLabs Limited also commits to reduce absolute scope 3 GHG emissions 22.5% within the same timeframe.* *The target boundary includes land-related emissions and removals from bioenergy feedstocks. Long-Term Targets: Aarti Pharmalabs Limited commits to reduce absolute scope 1 and 2 GHG emissions 90% by FY2050 from a FY2024 base year.* Aarti Pharmalabs Limited also commits to reduce absolute scope 3 GHG emissions 90% within the same timeframe.* *The target boundary includes land-related emissions and removals from bioenergy feedstocks.
Statut
Targets setAnnée cible
FY2050
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
INE0LRU01027
LEI
335800TTAKRBNDK5P363
Source : Science Based Targets initiative | Données publiques